Biogen (BIIB) Q3 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: Globe and Mail, The
Chief Executive Officer — Chris Viehbacher Head of Development — Priya Singhal Chief Financial Officer — Mike McDonnell President, Biogen US — Alisha Alaimo Interim Head of Investor Relations — Stephen Amato Takeaways Total Revenue -- $2.5 billion, a 3% decrease, with both total and core pharmaceutical revenue declining 3%. Non-GAAP Diluted EPS -- $4.08, reflecting a 6% decrease. Non-GAAP Operating Income -- Increased by 4%, indicating ongoing benefit from R&D prioritization and cost initiatives. MS Product Revenue -- Decreased approximately 9%, due to competitive and channel dynamics. SKYCLARYS Global Revenue -- $102 million, including $82 million in the US (an 8% sequential increase), now generating revenue in 15 countries outside the US; growth partially offset by pricing and reimbursement adjustments. Rare Disease Franchise Revenue -- $495 million, up 10% with continued strong performance from SKYCLARYS and QALSODY approvals in Switzerland and China. SPINR
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Jim Cramer reveals what to buy in this market now [Yahoo! Finance]Yahoo! Finance
- Iran War Inflation Could Take Years To Fade After Conflict Ends [Yahoo! Finance]Yahoo! Finance
- Fair Isaac (FICO) Q4 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- EQT AB (publ) (EQBBF) Q1 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ARI Q3 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
GS
Earnings
- 4/14/26 - Beat
GS
Sec Filings
- 4/22/26 - Form 424B2
- 4/22/26 - Form 424B2
- 4/22/26 - Form 424B2
- GS's page on the SEC website